shortness of breath; diminished vision in my rt eye; muscle weakness on the rt side of my face, both below my eye (upper cheek) and along my eyebrow; tingling/numbness in the area below my rt eye.; experience intermittent shooting pains on the right side of my face/head in the same areas described above; tingling/numbness in the area below my rt eye; tingling/numbness in the area below my rt eye; Exams of my eyes revealed that my rt pupil behaves abnormally when exposed to light; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Feb2021 19:15 (Lot number: EM9810) at the age of 30 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LORAZEPAM; MAGNESIUM. Vaccination history included: Flu vaccine, administration date: 04Dec2020, when the patient was 30 years old; Bnt162b2 (Dose: 01, prev dose lot number: EL3247, prev dose administration time=07:30PM, prev dose vaccine location=Left arm), administration date: 15Jan2021, when the patient was 30 years old, for Covid-19 immunization. The following information was reported: DYSPNOEA (non-serious) with onset Jul2021, outcome "not recovered", described as "shortness of breath"; VISUAL IMPAIRMENT (non-serious) with onset Jul2021, outcome "not recovered", described as "diminished vision in my rt eye"; FACIAL PARESIS (non-serious) with onset Jul2021, outcome "not recovered", described as "muscle weakness on the rt side of my face, both below my eye (upper cheek) and along my eyebrow"; EYE DISORDER (non-serious) with onset Jul2021, outcome "not recovered", described as "tingling/numbness in the area below my rt eye."; HEADACHE (non-serious) with onset Jul2021, outcome "not recovered", described as "experience intermittent shooting pains on the right side of my face/head in the same areas described above"; PARAESTHESIA (non-serious), HYPOAESTHESIA (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "tingling/numbness in the area below my rt eye"; PUPILLARY REFLEX IMPAIRED (non-serious) with onset Jul2021, outcome "not recovered", described as "Exams of my eyes revealed that my rt pupil behaves abnormally when exposed to light". The events "shortness of breath", "diminished vision in my rt eye", "muscle weakness on the rt side of my face, both below my eye (upper cheek) and along my eyebrow", "tingling/numbness in the area below my rt eye.", "experience intermittent shooting pains on the right side of my face/head in the same areas described above", "tingling/numbness in the area below my rt eye", "tingling/numbness in the area below my rt eye" and "exams of my eyes revealed that my rt pupil behaves abnormally when exposed to light" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dyspnoea, facial paresis, eye disorder, headache, paraesthesia, hypoaesthesia, pupillary reflex impaired. Therapeutic measures were taken as a result of visual impairment.  Additional information: The MRIs found no evidence of lesions suggesting MS. A change in patients eyeglass prescription did not correct the diminished vision. Patient was not diagnosed with covid-19 prior to vaccination. Since the vaccination, patient has not been tested for covid-19.  No follow-up attempts are possible. No further information is expected.